Rhuepo | List of Frontiers open access articles

Original Research

Published on 10 Apr 2018

Dynamics of Erythropoietic Biomarkers in Response to Treatment With Erythropoietin in Belgrade Rats

in Experimental Pharmacology and Drug Discovery

Ly M. Nguyen
Aman P. Singh
Pawel Wiczling
Wojciech Krzyzanski

Frontiers in Pharmacology

doi 10.3389/fphar.2018.00316

3,674 views
6 citations

Original Research

Published on 08 Jun 2023

Comparison between the influence of roxadustat and recombinant human erythropoietin treatment on blood pressure and cardio-cerebrovascular complications in patients undergoing peritoneal dialysis

in Nephrology

Shuiqin Cheng
Tingting Zhou
Le Yu
Zhihong Zhang
Yunmin Chen
Man Zhang
Jingjing Cui
Wenxin Yu
Jian Zhou
Yusheng Yu

Frontiers in Medicine

doi 10.3389/fmed.2023.1166024

5,213 views
6 citations

Case Report

Published on 24 Mar 2022

Case Report: Roxadustat in Combination With Rituximab Was Used to Treat EPO-Induced Pure Red Cell Aplasia

in Onconephrology

Xiaoe You
Baochun Guo
Zhen Wang
Hualin Ma
Ru Zhou
Lixia Liu
Xinzhou Zhang

Frontiers in Nephrology

doi 10.3389/fneph.2022.847847

3,241 views
2 citations

Original Research

Published on 20 Apr 2022

Dynamics of Erythroferrone Response to Erythropoietin in Rats

in Drug Metabolism and Transport

Peng Xu
Raymond S. M. Wong
Wojciech Krzyzanski
Xiaoyu Yan

Frontiers in Pharmacology

doi 10.3389/fphar.2022.876573

3,728 views
6 citations

Original Research

Published on 01 Jul 2024

Short-term effect of low-dose roxadustat combined with erythropoiesis-stimulating agent treatment for erythropoietin-resistant anemia in patients undergoing maintenance hemodialysis

in Renal Endocrinology

Qiaoying Xu
Jingjing Huang
Qingzhen Liu
Xueling Wang
Haiying Liu
Yan Song
Fulin Dou
Shasha Lv
Gang Liu

Frontiers in Endocrinology

doi 10.3389/fendo.2024.1372150

4,006 views
2 citations

Original Research

Published on 19 Apr 2017

Plant-Produced Asialo-Erythropoietin Restores Pancreatic Beta-Cell Function by Suppressing Mammalian Sterile-20-like Kinase (MST1) and Caspase-3 Activation

in Experimental Pharmacology and Drug Discovery

Elena Arthur
Farooqahmed S. Kittur
Yuan Lin
Chiu-Yueh Hung
David C. Sane
Jiahua Xie

Frontiers in Pharmacology

doi 10.3389/fphar.2017.00208

4,273 views
16 citations

Original Research

Published on 08 Oct 2025

Impact of roxadustat on anemia management in infected patients undergoing long-term dialysis: a retrospective cohort analysis

in Renal Pharmacology

Lulu Wang
Huimin Qiu
Xinqi Tan
Jing Liu
Ting Yang
Chunming Jiang

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1695376

2,119 views
1 citation

Articles

Dynamics of Erythropoietic Biomarkers in Response to Treatment With Erythropoietin in Belgrade Rats

Comparison between the influence of roxadustat and recombinant human erythropoietin treatment on blood pressure and cardio-cerebrovascular complications in patients undergoing peritoneal dialysis

Case Report: Roxadustat in Combination With Rituximab Was Used to Treat EPO-Induced Pure Red Cell Aplasia

Dynamics of Erythroferrone Response to Erythropoietin in Rats

Short-term effect of low-dose roxadustat combined with erythropoiesis-stimulating agent treatment for erythropoietin-resistant anemia in patients undergoing maintenance hemodialysis

Plant-Produced Asialo-Erythropoietin Restores Pancreatic Beta-Cell Function by Suppressing Mammalian Sterile-20-like Kinase (MST1) and Caspase-3 Activation

Impact of roxadustat on anemia management in infected patients undergoing long-term dialysis: a retrospective cohort analysis